Achievements and Progress Heading Into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook

GlobeNewswireDec 26, 2024 09:00 ET

While Institutions Own 25% of Cardiff Oncology, Inc. (NASDAQ:CRDF), Retail Investors Are Its Largest Shareholders With 57% Ownership

Yahoo FinanceDec 23, 2024 08:13 ET

James Levine Bought 13% More Shares In Cardiff Oncology

Simply Wall StDec 21, 2024 07:56 ET

Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Announces Target Price $10

Moomoo NewsDec 17, 2024 09:31 ET · Ratings

Piper Sandler Maintains Overweight on Cardiff Oncology, Raises Price Target to $10

BenzingaDec 13, 2024 08:14 ET · Ratings

Cardiff Oncology Analyst Ratings

BenzingaDec 13, 2024 08:13 ET · Ratings